Apimeds Pharmaceuticals US, Inc. (APUS)
1.69
+0.01
(+0.60%)
USD |
NYAM |
Jan 21, 12:51
Apimeds Pharmaceuticals US Price: 1.69 for Jan. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| NovaBay Pharmaceuticals, Inc. | 5.70 |
| Palatin Technologies, Inc. | 17.39 |
| Theriva Biologics, Inc. | 0.189 |
| Oragenics, Inc. | 0.9649 |
| NanoViricides, Inc. | 1.18 |
Price Related Metrics
| PEG Ratio | -0.0169 |
| Price to Book Value | 2.629 |
| Earnings Yield | -25.49% |
| Market Cap | 21.45M |
| PEGY Ratio | -0.0169 |